Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DADA Dada Nexus	$1.94 -2.5%	$1.99	$1.04 ▼ $2.52	$499.71M	1.33	2.06 million shs	3.89 million shs
FROG JFrog	$44.74 -0.3%	$42.15	$25.93 ▼ $46.64	$5.24B	1.06	1.47 million shs	780,983 shs
GDRX GoodRx	$4.67 -8.8%	$4.58	$3.31 ▼ $8.80	$1.78B	1.24	4.36 million shs	13.65 million shs

5G Stocks: The Path Forward is Profitable

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DADA Dada Nexus	0.00%	0.00%	0.00%	-5.61%	+38.21%
FROG JFrog	-0.51%	+6.37%	+6.22%	+3.05%	+65.30%
GDRX GoodRx	+37.27%	+47.13%	+9.40%	+28.97%	-28.59%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DADA Dada Nexus	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FROG JFrog	2.833 of 5 stars	2.5	3.0	0.0	0.0	4.1	3.3	0.6
GDRX GoodRx	2.042 of 5 stars	2.2	1.0	0.0	0.0	2.5	2.5	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DADA Dada Nexus	2.25	Hold	$2.95	52.45% Upside
FROG JFrog	2.94	Moderate Buy	$46.87	4.75% Upside
GDRX GoodRx	2.45	Hold	$5.80	24.20% Upside

Current Analyst Ratings Breakdown

Latest GDRX, DADA, and FROG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/11/2025	GDRX GoodRx	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold	$6.00
8/8/2025	GDRX GoodRx	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Outperform
8/8/2025	FROG JFrog	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
8/8/2025	FROG JFrog	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$50.00 ➝ $55.00
8/8/2025	FROG JFrog	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$46.00 ➝ $55.00
8/8/2025	FROG JFrog	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$45.00 ➝ $52.00
8/8/2025	FROG JFrog	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$46.00 ➝ $52.00
8/8/2025	FROG JFrog	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$45.00 ➝ $53.00
8/8/2025	FROG JFrog	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$40.00 ➝ $48.00
8/8/2025	FROG JFrog	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$46.00 ➝ $55.00
8/4/2025	FROG JFrog	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Outperform ➝ Outperform	$45.00 ➝ $47.00

(Data available from 8/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DADA Dada Nexus	$9.66B	0.05	N/A	N/A	$1.90 per share	1.02
FROG JFrog	$428.49M	12.19	N/A	N/A	$7.08 per share	6.32
GDRX GoodRx	$792.32M	2.05	$0.29 per share	16.09	$1.85 per share	2.52

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DADA Dada Nexus	-$279.28M	-$1.07	N/A	∞	N/A	-21.09%	-11.01%	-8.22%	N/A
FROG JFrog	-$69.24M	-$0.77	N/A	N/A	N/A	-18.18%	-7.54%	-5.20%	11/6/2025 (Estimated)
GDRX GoodRx	$16.39M	$0.10	46.70	25.94	2.10	4.33%	8.86%	4.50%	11/6/2025 (Estimated)

Latest GDRX, DADA, and FROG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/7/2025	Q2 2025	FROG JFrog	$0.16	$0.18	+$0.02	-$0.19	$122.80 million	$127.20 million
8/6/2025	Q2 2025	GDRX GoodRx	$0.10	$0.09	-$0.01	$0.04	$205.72 million	$203.07 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DADA Dada Nexus	N/A	N/A	N/A	N/A	N/A
FROG JFrog	N/A	N/A	N/A	N/A	N/A
GDRX GoodRx	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DADA Dada Nexus	N/A	3.27	3.27
FROG JFrog	N/A	2.13	2.13
GDRX GoodRx	0.75	4.21	4.21

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DADA Dada Nexus	59.25%
FROG JFrog	85.02%
GDRX GoodRx	63.77%

Insider Ownership

Company	Insider Ownership
DADA Dada Nexus	8.50%
FROG JFrog	14.10%
GDRX GoodRx	4.17%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DADA Dada Nexus	3,130	258.25 million	236.30 million	Optionable
FROG JFrog	1,600	116.74 million	100.28 million	Optionable
GDRX GoodRx	950	347.45 million	332.96 million	Optionable

GDRX, DADA, and FROG Headlines

Recent News About These Companies

Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk’s breakup with Hims

3 hours ago | msn.com

Is Novo Nordisk deal the much-needed catalyst for Goodrx stock?

August 19 at 10:03 AM | msn.com

GoodRx and Novo Nordisk unveil $499 monthly offer for Ozempic and Wegovy

August 19 at 10:03 AM | thepharmaletter.comT

Why GoodRx (GDRX) Stock Is Trading Up Today

August 19 at 10:03 AM | finance.yahoo.com

Stock Movers: Novo Nordisk, GoodRX, CVS

August 18 at 2:45 PM | bloomberg.com

Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers

August 18 at 2:45 PM | msn.com

GoodRx: After A 30% Surge On The Novo News, Is The Story Just Beginning?

August 18 at 2:36 PM | seekingalpha.com

Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with Hims

August 18 at 1:40 PM | fastcompany.comF

Novo Nordisk expands access to Ozempic, Wegovy through GoodRx and other platforms

August 18 at 11:26 AM | proactiveinvestors.com

GoodRx Stock Spikes 35% on Novo Nordisk Collaboration. They're Offering Ozempic for $499 a Month.

August 18 at 9:53 AM | barrons.com

Novo Nordisk to offer Ozempic at $499 per month to cash-paying US customers

August 18 at 9:43 AM | reuters.com

GoodRx begins selling Novo Nordisk GLP-1s for cash price

August 18 at 9:43 AM | msn.com

GoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month

August 18 at 9:43 AM | msn.com

GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month

August 18 at 9:05 AM | businesswire.com

GoodRx (GDRX) Lifts Guidance as Pharma Partnerships Drive Double-Digit Growth

August 17 at 11:40 PM | msn.com

GoodRx (NASDAQ:GDRX) Trading Up 5.2% - Here's What Happened

August 17 at 1:40 PM | marketbeat.com

Citi Keeps Their Buy Rating on GoodRx Holdings (GDRX)

August 16 at 3:29 AM | theglobeandmail.com

GoodRx Holdings' (NASDAQ:GDRX) Performance Is Even Better Than Its Earnings Suggest

August 14, 2025 | finance.yahoo.com

GoodRx Holdings, Inc. (NASDAQ:GDRX) Stake Boosted by Connor Clark & Lunn Investment Management Ltd.

August 14, 2025 | marketbeat.com

Persistent Asset Partners Ltd Acquires New Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX)

August 13, 2025 | marketbeat.com

The Top 5 Analyst Questions From GoodRx’s Q2 Earnings Call

August 13, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

GDRX, DADA, and FROG Company Descriptions

Dada Nexus NASDAQ:DADA

Dada Nexus Limited operates a platform of local on-demand retail and delivery in the People's Republic of China. It operates Dada Now, a local on-demand delivery platform that provides intra-city delivery and last-mile delivery services on an on-demand basis to chain merchants, small- and medium-sized enterprise merchants, and individual senders; and JDDJ, a local on-demand retail platforms for consumers, retailers, and brand owners. The company was incorporated in 2014 and is headquartered in Shanghai, China.

JFrog NASDAQ:FROG

$44.74 -0.14 (-0.31%)

Closing price 04:00 PM Eastern

Extended Trading

$44.68 -0.06 (-0.13%)

As of 07:56 PM Eastern

JFrog Ltd. provides end-to-end hybrid software supply chain platform in the United States, Israel, India, and internationally. The company offers JFrog Artifactory, a package repository that allows teams and organizations to store, update, and manage their software packages; JFrog Curation that functions as a guardian outside the software development pipeline, controlling the admission of packages into an organization, primarily from open source or public repositories; JFrog Xray, which scans JFrog Artifactory to secure all software packages; JFrog Advanced Security, an optional add-on for select JFrog subscriptions; and JFrog Distribution that provides software package distribution. It also provides JFrog Artifactory Edge that utilizes and leverages metadata from JFrog Artifactory to facilitate the transfer of the incremental changes in software packages from their previous versions; JFrog Mission Control, a platform control panel that provides a view of moving pieces of an organization's software supply chain workflow; JFrog Insight, a DevOps intelligence tool; JFrog Connect, a device management solution that allows companies to manage software updates and monitor performance in IoT device fleets; and JFrog Pipelines, a continuous integration and delivery tool for automating and orchestrating the movement of software packages. In addition, the company provides JFrog Pro that provides access to the universal version of JFrog Artifactory and ongoing updates, upgrades, and bug fixes; JFrog Pro X, a self-hosted-only subscription; JFrog Enterprise X, which offers cluster configuration, federated repositories, multi-region replication, larger enterprise-scale deployments, service-level agreement support, and deeper security; and JFrog Enterprise Plus, a full platform subscription option. It serves technology, financial services, retail, healthcare, and telecommunications organizations. JFrog Ltd. was incorporated in 2008 and is headquartered in Sunnyvale, California.

GoodRx NASDAQ:GDRX

$4.67 -0.45 (-8.79%)

Closing price 04:00 PM Eastern

Extended Trading

$4.70 +0.03 (+0.54%)

As of 07:58 PM Eastern

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time